Pregabalin 50 mg & Duloxetine 20 mg .. . . .. . .

Dec 28, 2023

Pregabalin 50 mg & Duloxetine 20 mg
DULOXTIME PREGA
Pregabalin:

Class: Pregabalin is an anticonvulsant and anxiolytic medication.
Mechanism of Action: It binds to calcium channels in the central nervous system, modulating the release of neurotransmitters. Its exact mechanism in treating neuropathic pain is not fully understood.
Indications: Pregabalin is commonly used to treat neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, and partial-onset seizures.
Duloxetine:

Class: Duloxetine is a selective serotonin and norepinephrine reuptake inhibitor (SNRI).
Mechanism of Action: It inhibits the reuptake of both serotonin and norepinephrine, increasing the levels of these neurotransmitters in the central nervous system. This mechanism is believed to contribute to its analgesic (pain-relieving) effects.
Indications: Duloxetine is used for the treatment of generalized anxiety disorder, major depressive disorder, fibromyalgia, chronic musculoskeletal pain, and neuropathic pain associated with conditions such as diabetic peripheral neuropathy and chronic low back pain.Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 5 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
info@sterispharma.com
order now:https://www.sterisonline.com/product/duloxtime-prega-134317

SHARE WITH